Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats
The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal phar...
Gespeichert in:
Veröffentlicht in: | Current Protocols in Pharmacology 2019-06, Vol.85 (1), p.e58-n/a |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 1 |
container_start_page | e58 |
container_title | Current Protocols in Pharmacology |
container_volume | 85 |
creator | Voelkner, Nivea M. F. Voelkner, Alexander Derendorf, Hartmut |
description | The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc. |
doi_str_mv | 10.1002/cpph.58 |
format | Article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_cpph_58</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CPPH58</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2328-9447f24f1e0513fdabd518f0ee9487cac18082d9b43a3ebeae5b06dfc30892da3</originalsourceid><addsrcrecordid>eNp1kMtKw0AUhgdRbKnFN5DZuZDUuSWdLCVVq1QMXtbhzM0O5kYmInl7U6rdufrPgY-Pc36EzilZUELYtW7b7SKWR2hKUy4iyVJyfJglm6B5CF4RIhKRUEFP0YRTwhLK5BQ9rmxvu8rX0Pumxo3Dq3GFEudbGFM3n762vdcBqwE_ed01xkM5BB_wK1Rt6esP7Gv8An04QycOymDnvzlD73e3b9k62jzfP2Q3m0gzzmSUCrF0TDhqSUy5M6BMTKUj1qZCLjVoKolkJlWCA7fKgo0VSYzTnMiUGeAzdLn3jseE0FlXtJ2voBsKSopdIcWukCKWI3mxJ9svVVlz4P7eH4GrPfDtSzv85ymyPF-Puh-mo2qs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Voelkner, Nivea M. F. ; Voelkner, Alexander ; Derendorf, Hartmut</creator><creatorcontrib>Voelkner, Nivea M. F. ; Voelkner, Alexander ; Derendorf, Hartmut</creatorcontrib><description>The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc.</description><identifier>ISSN: 1934-8282</identifier><identifier>EISSN: 1934-8290</identifier><identifier>DOI: 10.1002/cpph.58</identifier><identifier>PMID: 31026128</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; dermal ; Male ; Microdialysis ; Pharmaceutical Preparations - metabolism ; Pharmacokinetics ; rats ; Rats, Wistar ; Skin - metabolism</subject><ispartof>Current Protocols in Pharmacology, 2019-06, Vol.85 (1), p.e58-n/a</ispartof><rights>2019 John Wiley & Sons, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2328-9447f24f1e0513fdabd518f0ee9487cac18082d9b43a3ebeae5b06dfc30892da3</citedby><cites>FETCH-LOGICAL-c2328-9447f24f1e0513fdabd518f0ee9487cac18082d9b43a3ebeae5b06dfc30892da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31026128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Voelkner, Nivea M. F.</creatorcontrib><creatorcontrib>Voelkner, Alexander</creatorcontrib><creatorcontrib>Derendorf, Hartmut</creatorcontrib><title>Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats</title><title>Current Protocols in Pharmacology</title><addtitle>Curr Protoc Pharmacol</addtitle><description>The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc.</description><subject>Animals</subject><subject>dermal</subject><subject>Male</subject><subject>Microdialysis</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmacokinetics</subject><subject>rats</subject><subject>Rats, Wistar</subject><subject>Skin - metabolism</subject><issn>1934-8282</issn><issn>1934-8290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKw0AUhgdRbKnFN5DZuZDUuSWdLCVVq1QMXtbhzM0O5kYmInl7U6rdufrPgY-Pc36EzilZUELYtW7b7SKWR2hKUy4iyVJyfJglm6B5CF4RIhKRUEFP0YRTwhLK5BQ9rmxvu8rX0Pumxo3Dq3GFEudbGFM3n762vdcBqwE_ed01xkM5BB_wK1Rt6esP7Gv8An04QycOymDnvzlD73e3b9k62jzfP2Q3m0gzzmSUCrF0TDhqSUy5M6BMTKUj1qZCLjVoKolkJlWCA7fKgo0VSYzTnMiUGeAzdLn3jseE0FlXtJ2voBsKSopdIcWukCKWI3mxJ9svVVlz4P7eH4GrPfDtSzv85ymyPF-Puh-mo2qs</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Voelkner, Nivea M. F.</creator><creator>Voelkner, Alexander</creator><creator>Derendorf, Hartmut</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201906</creationdate><title>Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats</title><author>Voelkner, Nivea M. F. ; Voelkner, Alexander ; Derendorf, Hartmut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2328-9447f24f1e0513fdabd518f0ee9487cac18082d9b43a3ebeae5b06dfc30892da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>dermal</topic><topic>Male</topic><topic>Microdialysis</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmacokinetics</topic><topic>rats</topic><topic>Rats, Wistar</topic><topic>Skin - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Voelkner, Nivea M. F.</creatorcontrib><creatorcontrib>Voelkner, Alexander</creatorcontrib><creatorcontrib>Derendorf, Hartmut</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Current Protocols in Pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voelkner, Nivea M. F.</au><au>Voelkner, Alexander</au><au>Derendorf, Hartmut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats</atitle><jtitle>Current Protocols in Pharmacology</jtitle><addtitle>Curr Protoc Pharmacol</addtitle><date>2019-06</date><risdate>2019</risdate><volume>85</volume><issue>1</issue><spage>e58</spage><epage>n/a</epage><pages>e58-n/a</pages><issn>1934-8282</issn><eissn>1934-8290</eissn><abstract>The evaluation of absorption and availability at the site of action of a drug candidate is an important element of drug discovery and development, as clinical response is a function of the bioavailability of the active agent and its continued presence at the site of action. Evaluation of dermal pharmacokinetics facilitates the selection of new compounds or chemical structures for advancement as possible clinical candidates. An advantage of microdialysis is that it allows the measurement of compound concentrations at the site of action without disturbing the tissue milieu, making it possible to determine the relationship between this important variable and plasma concentrations of the agent. Described in this unit are laboratory protocols for performing dermal microdialysis experiments in rat for the purpose of defining the pharmacokinetics parameters of test agents. © 2019 by John Wiley & Sons, Inc.</abstract><cop>United States</cop><pmid>31026128</pmid><doi>10.1002/cpph.58</doi><tpages>17</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1934-8282 |
ispartof | Current Protocols in Pharmacology, 2019-06, Vol.85 (1), p.e58-n/a |
issn | 1934-8282 1934-8290 |
language | eng |
recordid | cdi_crossref_primary_10_1002_cpph_58 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Animals dermal Male Microdialysis Pharmaceutical Preparations - metabolism Pharmacokinetics rats Rats, Wistar Skin - metabolism |
title | Determination of Dermal Pharmacokinetics by Microdialysis Sampling in Rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A44%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20Dermal%20Pharmacokinetics%20by%20Microdialysis%20Sampling%20in%20Rats&rft.jtitle=Current%20Protocols%20in%20Pharmacology&rft.au=Voelkner,%20Nivea%20M.%20F.&rft.date=2019-06&rft.volume=85&rft.issue=1&rft.spage=e58&rft.epage=n/a&rft.pages=e58-n/a&rft.issn=1934-8282&rft.eissn=1934-8290&rft_id=info:doi/10.1002/cpph.58&rft_dat=%3Cwiley_cross%3ECPPH58%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/31026128&rfr_iscdi=true |